OUR PRODUCTS

MOBILE APPS

GENERAL INFO

HUMA

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Humacyte (HUMA) Earnings Date & Reports

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

HUMA is expected to report earnings to fall 33.71% to -15 cents per share on November 07

Q3'25

Est.

$-0.16

Q2'25

Missed

by $0.08

Q1'25

Beat

by $0.48

Q4'24

Beat

by $0.09

Q3'24

Missed

by $0.08

The last earnings report on August 11 showed earnings per share of -23 cents, missing the estimate of -15 cents. With 1.22M shares outstanding, the current market capitalization sits at 245.48M.

View a ticker or compare two or three

Compare

HUMA

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For HUMA
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. HUMA showed earnings on August 11, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

2525 East North Carolina Highway 54

Phone

+1 919 313-9633

Employees

185

Web

https://www.humacyte.com